In an era of increasingly individualized healthcare, Elizabeth Philp has become a significant force of innovation, especially in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a drive to make custom medications more obtainable, questioning the standard one-size-fit